Literature DB >> 10506209

Physical and functional interaction between p53 and the Werner's syndrome protein.

G Blander1, J Kipnis, J F Leal, C E Yu, G D Schellenberg, M Oren.   

Abstract

Werner's syndrome is a human autosomal recessive disorder leading to premature aging. The mutations responsible for this disorder have recently been localized to a gene (WRN) encoding a protein that possesses DNA helicase and exonuclease activities. Patients carrying WRN gene mutations exhibit an elevated rate of cancer, accompanied by increased genomic instability. The latter features are also characteristic of the loss of function of p53, a tumor suppressor that is very frequently inactivated in human cancer. Moreover, changes in the activity of p53 have been implicated in the onset of cellular replicative senescence. We report here that the WRN protein can form a specific physical interaction with p53. This interaction involves the carboxyl-terminal part of WRN and the extreme carboxyl terminus of p53, a region that plays an important role in regulating the functional state of p53. A small fraction of WRN can be found in complex with endogenous p53 in nontransfected cells. Overexpression of WRN leads to augmented p53-dependent transcriptional activity and induction of p21(Waf1) protein expression. These findings support the existence of a cross-talk between WRN and p53, which may be important for maintaining genomic integrity and for preventing the accumulation of aberrations that can give rise to premature senescence and cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10506209     DOI: 10.1074/jbc.274.41.29463

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Mutations in the WRN gene in mice accelerate mortality in a p53-null background.

Authors:  D B Lombard; C Beard; B Johnson; R A Marciniak; J Dausman; R Bronson; J E Buhlmann; R Lipman; R Curry; A Sharpe; R Jaenisch; L Guarente
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.

Authors:  Robert Y L Tsai; Ronald D G McKay
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

3.  Werner protein recruits DNA polymerase delta to the nucleolus.

Authors:  A M Szekely; Y H Chen; C Zhang; J Oshima; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

4.  Analysis of the unwinding activity of the dimeric RECQ1 helicase in the presence of human replication protein A.

Authors:  Sheng Cui; Daniele Arosio; Kevin M Doherty; Robert M Brosh; Arturo Falaschi; Alessandro Vindigni
Journal:  Nucleic Acids Res       Date:  2004-04-19       Impact factor: 16.971

Review 5.  RecQ helicases; at the crossroad of genome replication, repair, and recombination.

Authors:  Sarallah Rezazadeh
Journal:  Mol Biol Rep       Date:  2011-09-23       Impact factor: 2.316

Review 6.  Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.

Authors:  J J P Perry; L Fan; J A Tainer
Journal:  Neuroscience       Date:  2006-12-15       Impact factor: 3.590

Review 7.  Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

8.  Expression of Werner syndrome gene in hypothalamic neurons in physiological aging.

Authors:  E D Bazhanova; I G Popovich; V N Anisimov
Journal:  Dokl Biol Sci       Date:  2014-01-03

9.  Depletion of WRN enhances DNA damage in HeLa cells exposed to the benzene metabolite, hydroquinone.

Authors:  Noé Galván; Sophia Lim; Stephan Zmugg; Martyn T Smith; Luoping Zhang
Journal:  Mutat Res       Date:  2007-08-07       Impact factor: 2.433

10.  Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.

Authors:  Margaret S Lee; Mina Yaar; Mark S Eller; Thomas M Rünger; Ying Gao; Barbara A Gilchrest
Journal:  J Dermatol Sci       Date:  2009-11-10       Impact factor: 4.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.